Strain for producing nattokinase and production method therefor
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Nov 19, 2024
Grant Date -
Mar 24, 2022
app pub date -
Jul 2, 2019
filing date -
Jul 2, 2019
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are a strain for producing nattokinase and a production method therefor. In particular, the present invention involves a novel strain capable of producing nattokinase, i.e. Bacillus subtilis natto ST-1086, deposited at the China General Microbiological Culture Collection Center under CGMCC No. 17895. The present invention further involves a method for producing a nattokinase product by means of using the novel strain CGMCC No. 17895 of the present application, wherein the resulting nattokinase product can be used as a drug for dissolving thrombi. The present invention further involves the use of the nattokinase product of the present application for preparing a composition for dissolving thrombi and in a method for treating thrombi.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2019 Application Filing Year
- A61K Class
- 21422 Applications Filed
- 10424 Patents Issued To-Date
- 48.67 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 1 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | May 19, 2028 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | May 19, 2032 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | May 19, 2036 |